AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29266689 — intervention group
Group type: EXPERIMENTAL
Intervention: Social support from nonfamily adults
Number of subjects: 1519
Study 29266689 — intervention group
Group type: EXPERIMENTAL
Intervention: Three sources of social support
Number of subjects: 1519
Study 29266689 — intervention group
Group type: EXPERIMENTAL
Intervention: Various forms of social support (except for encouragement)
Number of subjects: 1519
Study 29266689 — intervention group
Group type: EXPERIMENTAL
Intervention: Social support in early‐middle puberty
Number of subjects: 1519
Study 29266689 — intervention group
Group type: EXPERIMENTAL
Intervention: Social support
Number of subjects: 1519
Study 29266689 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate‐to‐vigorous PA in late‐post puberty
Number of subjects: 1519
Study 26903145 — intervention group
Group type: EXPERIMENTAL
Intervention: Swimming group (SG) - 50 minutes of swimming 3 times a week for 12 weeks
Number of subjects: 75
Study 26903145 — intervention group
Group type: COMPARATOR
Intervention: Walking group (WG) - walking with a heart rate at the anaerobic threshold, same duration and frequency as SG
Number of subjects: 75
Study 26903145 — intervention group
Group type: EXPERIMENTAL
Intervention: Swimming group (SG)
Number of subjects: 75
Study 26903145 — intervention group
Group type: COMPARATOR
Intervention: Walking group (WG)
Number of subjects: 75
Study 25428264 — intervention group
Group type: EXPERIMENTAL
Intervention: Test-treat package
Number of subjects: 0
Study 25428264 — intervention group
Group type: COMPARATOR
Intervention: Routine outpatient care
Number of subjects: 0
Study 21120497 — intervention group
Group type: EXPERIMENTAL
Intervention: Active laser therapy with a dosage of 1.2 J/per painful point
Number of subjects: 60
Study 21120497 — intervention group
Group type: EXPERIMENTAL
Intervention: Active laser therapy with a dosage of 0.6 J/per painful point
Number of subjects: 60
Study 21120497 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 60
Study 20590735 — intervention group
Group type: EXPERIMENTAL
Intervention: liraglutide 1.2 mg
Number of subjects: 732
Study 20590735 — intervention group
Group type: EXPERIMENTAL
Intervention: liraglutide 1.8 mg
Number of subjects: 732
Study 20590735 — intervention group
Group type: COMPARATOR
Intervention: glimepiride 8 mg
Number of subjects: 732
Study 17286346 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.8 g/kg alcohol
Number of subjects: 30
Study 17286346 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0 g/kg)
Number of subjects: 30
Study 16119597 — intervention group
Group type: EXPERIMENTAL
Intervention: morphine 5 mg
Number of subjects: 72
Study 16119597 — intervention group
Group type: EXPERIMENTAL
Intervention: morphine 1 mg with methylprednisolone 40 mg
Number of subjects: 72
Study 16119597 — intervention group
Group type: COMPARATOR
Intervention: saline
Number of subjects: 72
Study 16119597 — intervention group
Group type: COMPARATOR
Intervention: morphine 1 mg
Number of subjects: 72
Study 12397734 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutamine-rich Stresson Multi Fibre diet
Number of subjects: 36
Study 12397734 — intervention group
Group type: COMPARATOR
Intervention: Nutrison Multi Fibre glutamine-poor diet
Number of subjects: 36
Study 10192751 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical heparin (1000 IU x g(‐1), applied three times daily for a maximum of 7 days)
Number of subjects: 132
Study 10192751 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 132
Study 10192751 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical heparin
Number of subjects: 132
Study 10192751 — intervention group
Group type: COMPARATOR
Intervention: Topical heparin and Placebo
Number of subjects: 132
Study 7587700 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG instillation therapy
Number of subjects: 441
Study 7587700 — intervention group
Group type: EXPERIMENTAL
Intervention: TTP instillation therapy
Number of subjects: 441
Study 7587700 — intervention group
Group type: EXPERIMENTAL
Intervention: MMC instillation therapy
Number of subjects: 441
Study 7587700 — intervention group
Group type: COMPARATOR
Intervention: Control group (no instillation therapy)
Number of subjects: 441
Study 2271367 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomipramine (75 mg for extensive metabolisers, 50 mg for poor metabolisers)
Number of subjects: 19
Study 2271367 — intervention group
Group type: EXPERIMENTAL
Intervention: Desipramine (200 mg for extensive metabolisers, 50 mg for poor metabolisers)
Number of subjects: 19
Study 2271367 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 231736 — intervention group
Group type: EXPERIMENTAL
Intervention: delta‐9‐tetrahydrocannabinol (THC)
Number of subjects: 0
Study 231736 — intervention group
Group type: COMPARATOR
Intervention: metoclopramide syrup
Number of subjects: 0
Study 231736 — intervention group
Group type: COMPARATOR
Intervention: prochlorperazine tablets
Number of subjects: 0
Study 31564689 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy using purified cedar allergen
Number of subjects: 0
Study 31564689 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy
Number of subjects: 0
Study 29692285 — intervention group
Group type: EXPERIMENTAL
Intervention: Metacognitive Reflection and Insight Therapy (MERIT), 40 sessions
Number of subjects: 70
Study 29692285 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (Control)
Number of subjects: 70
Study 28734816 — intervention group
Group type: EXPERIMENTAL
Intervention: Portable nonmydriatic fundus camera
Number of subjects: 211
Study 28734816 — intervention group
Group type: COMPARATOR
Intervention: Standard mydriatic fundus camera
Number of subjects: 211
Study 25728339 — intervention group
Group type: EXPERIMENTAL
Intervention: Coach education sessions for coaches (2 sessions lasting approximately 2 hours each)
Number of subjects: 76
Study 25728339 — intervention group
Group type: COMPARATOR
Intervention: Control group (no coach education)
Number of subjects: 76
Study 23325450 — intervention group
Group type: EXPERIMENTAL
Intervention: IPE 4 g/day
Number of subjects: 931
Study 23325450 — intervention group
Group type: EXPERIMENTAL
Intervention: IPE 2 g/day
Number of subjects: 931
Study 23325450 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 931
Study 21289266 — intervention group
Group type: EXPERIMENTAL
Intervention: hCG 15 IU sc every other day for 10 days
Number of subjects: 23
Study 21289266 — intervention group
Group type: EXPERIMENTAL
Intervention: hCG 60 IU sc every other day for 10 days
Number of subjects: 23
Study 21289266 — intervention group
Group type: EXPERIMENTAL
Intervention: hCG 125 IU sc every other day for 10 days
Number of subjects: 23
Study 21289266 — intervention group
Group type: COMPARATOR
Intervention: GnRH antagonist acyline
Number of subjects: 23
Study 21289266 — intervention group
Group type: COMPARATOR
Intervention: Control group (0 IU hCG)
Number of subjects: 23
Study 19190344 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg supplemental vitamin E (alpha‐tocopherol) per day
Number of subjects: 1833
Study 19190344 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic variation in TTPA and SEC14L2
Number of subjects: 1833
Study 16723156 — intervention group
Group type: EXPERIMENTAL
Intervention: High doses of intravenous methylprednisolone
Number of subjects: 32
Study 12969098 — intervention group
Group type: EXPERIMENTAL
Intervention: Electro-acupuncture (EA)
Number of subjects: 45
Study 12969098 — intervention group
Group type: COMPARATOR
Intervention: Sham
Number of subjects: 45
Study 12969098 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (EA and Sham)
Number of subjects: 45
Study 11115208 — intervention group
Group type: EXPERIMENTAL
Intervention: Guideline-concordant antidepressant medication or specialty counseling
Number of subjects: 92
Study 11115208 — intervention group
Group type: EXPERIMENTAL
Intervention: Severity of physical problems
Number of subjects: 92
Study 8884819 — intervention group
Group type: EXPERIMENTAL
Intervention: Demineralized bone powder
Number of subjects: 14
Study 8884819 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 14
Study 1528609 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose antigen injection
Number of subjects: 5
Study 1528609 — intervention group
Group type: COMPARATOR
Intervention: Placebo injections
Number of subjects: 5
Study 3877291 — intervention group
Group type: COMPARATOR
Intervention: No premedication
Number of subjects: 120
Study 3877291 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam 10 mg orally
Number of subjects: 120
Study 3877291 — intervention group
Group type: EXPERIMENTAL
Intervention: Pethidine 50‐75 mg intramuscularly and atropine 0.6 mg intramuscularly
Number of subjects: 120
Study 31862740 — intervention group
Group type: EXPERIMENTAL
Intervention: Fascia iliaca compartment block (FICB) administered by trained paramedics
Number of subjects: 7
Study 31862740 — intervention group
Group type: COMPARATOR
Intervention: Usual care (most commonly morphine)
Number of subjects: 7
Study 29246363 — intervention group
Group type: EXPERIMENTAL
Intervention: Brain natriuretic peptide (≥100 pg/mL)
Number of subjects: 521
Study 29246363 — intervention group
Group type: EXPERIMENTAL
Intervention: TNF‐α (≥5.6 pg/mL)
Number of subjects: 521
Study 29246363 — intervention group
Group type: EXPERIMENTAL
Intervention: Troponin (≥0.01 ng/mL)
Number of subjects: 521
Study 29246363 — intervention group
Group type: EXPERIMENTAL
Intervention: Left ventricular mass
Number of subjects: 521
Study 29246363 — intervention group
Group type: EXPERIMENTAL
Intervention: Left atrial internal dimension
Number of subjects: 521
Study 29246363 — intervention group
Group type: EXPERIMENTAL
Intervention: E/Em ratio (diastolic dysfunction)
Number of subjects: 521
Study 27029746 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen use
Number of subjects: 0
Study 27029746 — intervention group
Group type: EXPERIMENTAL
Intervention: Tubal ligation
Number of subjects: 0
Study 27029746 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptive use
Number of subjects: 0
Study 27029746 — intervention group
Group type: EXPERIMENTAL
Intervention: History of ectopic pregnancy
Number of subjects: 0
Study 25267716 — intervention group
Group type: EXPERIMENTAL
Intervention: ezetimibe/simvastatin 10/40 mg/day
Number of subjects: 1359
Study 25267716 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 1359
Study 21897297 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure-Controlled Ventilation (PCV)
Number of subjects: 40
Study 21897297 — intervention group
Group type: COMPARATOR
Intervention: Volume-Controlled Ventilation (VCV)
Number of subjects: 40
Study 21149931 — intervention group
Group type: EXPERIMENTAL
Intervention: NEUMUNE (5‐androstenediol injectable suspension) administered intramuscularly at doses of 50, 100, 200 or 400 mg, either as a single injection or once daily for five consecutive days
Number of subjects: 129
Study 21149931 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 129
Study 18057405 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine supplement
Number of subjects: 10
Study 18057405 — intervention group
Group type: COMPARATOR
Intervention: Placebo supplement
Number of subjects: 10
Study 16598180 — intervention group
Group type: EXPERIMENTAL
Intervention: One-step conventional adhesive system (PQ1) with 35% phosphoric acid etching for 60 seconds
Number of subjects: 0
Study 16598180 — intervention group
Group type: COMPARATOR
Intervention: Self-etching adhesive system (Adper Prompt L Pop) applied without prior acid etching
Number of subjects: 0
Study 12112791 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmeterol xinafoate inhalation before sleep
Number of subjects: 23
Study 12112791 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 11951580 — intervention group
Group type: EXPERIMENTAL
Intervention: Hymecromone (300 mg tablets at a dosage of 1,200 mg/day, 2 tablets midday and evening)
Number of subjects: 123
Study 11951580 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 123
Study 11951580 — intervention group
Group type: EXPERIMENTAL
Intervention: Hymecromone
Number of subjects: 123
Study 9605674 — intervention group
Group type: COMPARATOR
Intervention: 0.0 MAC (control)
Number of subjects: 8
Study 9605674 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.6 MAC desflurane
Number of subjects: 8
Study 9605674 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 MAC desflurane
Number of subjects: 8
Study 7908864 — intervention group
Group type: EXPERIMENTAL
Intervention: BRL 35135 (8 mg)
Number of subjects: 8
Study 7908864 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol (8 mg)
Number of subjects: 8
Study 7908864 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 7908864 — intervention group
Group type: COMPARATOR
Intervention: Bisoprolol (5 mg)
Number of subjects: 8
Study 7908864 — intervention group
Group type: COMPARATOR
Intervention: Nadolol (20 mg)
Number of subjects: 8
Study 3048052 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensified conventional treatment (ICT)
Number of subjects: 102
Study 3048052 — intervention group
Group type: COMPARATOR
Intervention: Regular treatment (RT)
Number of subjects: 102
Study 30575798 — intervention group
Group type: EXPERIMENTAL
Intervention: ω‐3 supplementation (triglyceride dietary supplements or prescription ethyl esters)
Number of subjects: 0
Study 30575798 — intervention group
Group type: EXPERIMENTAL
Intervention: Endotoxin challenge (low dose intravenous lipopolysaccharide)
Number of subjects: 0
Study 30575798 — intervention group
Group type: EXPERIMENTAL
Intervention: ω‐3 supplementation
Number of subjects: 0
Study 30575798 — intervention group
Group type: COMPARATOR
Intervention: Placebo (in Study B)
Number of subjects: 0
Study 30575798 — intervention group
Group type: EXPERIMENTAL
Intervention: Endotoxin challenge
Number of subjects: 0
Study 27939192 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided serratus anterior plane block (SAPB) with 30 mL of 0.25% levobupivacaine followed by 5 mL/hour of 0.125% levobupivacaine
Number of subjects: 40
Study 27939192 — intervention group
Group type: COMPARATOR
Intervention: Thoracic epidural analgesia (TEA) with a lower dose regimen activated before extubation
Number of subjects: 40
Study 26576533 — intervention group
Group type: EXPERIMENTAL
Intervention: Early adjuvant radiotherapy for 6 weeks (60 Gy in 30 fractions)
Number of subjects: 190
Study 26576533 — intervention group
Group type: COMPARATOR
Intervention: Active monitoring
Number of subjects: 190
Study 23545279 — intervention group
Group type: EXPERIMENTAL
Intervention: nab-paclitaxel (nab-P) 100 mg/m² weekly + carboplatin (C)
Number of subjects: 149
Study 23545279 — intervention group
Group type: COMPARATOR
Intervention: solvent-based paclitaxel (sb-P) 200 mg/m² every 3 weeks + carboplatin (C)
Number of subjects: 149
Study 23545279 — intervention group
Group type: EXPERIMENTAL
Intervention: nab-P + C
Number of subjects: 149
Study 23545279 — intervention group
Group type: COMPARATOR
Intervention: sb-P + C
Number of subjects: 149
Study 21576081 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic electrocautery of the ovaries
Number of subjects: 168
Study 21576081 — intervention group
Group type: COMPARATOR
Intervention: Immediate rFSH
Number of subjects: 168
Study 19047840 — intervention group
Group type: EXPERIMENTAL
Intervention: Specially processed cereals
Number of subjects: 26
Study 19047840 — intervention group
Group type: COMPARATOR
Intervention: Nonprocessed cereals
Number of subjects: 26
Study 16556178 — intervention group
Group type: EXPERIMENTAL
Intervention: Rennie alginate
Number of subjects: 12
Study 16556178 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 16556178 — intervention group
Group type: COMPARATOR
Intervention: Gaviscon
Number of subjects: 12
Study 14689840 — intervention group
Group type: EXPERIMENTAL
Intervention: NILS-Longitudinal Study of Aging (NILS-LSA)
Number of subjects: 2300
Study 10878692 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil SR 180 mg/trandolapril 2 mg (VT)
Number of subjects: 100
Study 10878692 — intervention group
Group type: COMPARATOR
Intervention: Captopril 50 mg/hydrochlorothiazide 25 mg (CH)
Number of subjects: 100
Study 9128476 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-Management Program (cognitive-behavioural intervention)
Number of subjects: 65
Study 1408866 — intervention group
Group type: EXPERIMENTAL
Intervention: Taped relaxation message
Number of subjects: 26
Study 1408866 — intervention group
Group type: COMPARATOR
Intervention: Sitting quietly (Control)
Number of subjects: 26
Study 30107236 — intervention group
Group type: EXPERIMENTAL
Intervention: Fact sheet
Number of subjects: 108
Study 30107236 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing techniques (MI)
Number of subjects: 108
Study 30107236 — intervention group
Group type: EXPERIMENTAL
Intervention: Web site
Number of subjects: 108
Study 30107236 — intervention group
Group type: EXPERIMENTAL
Intervention: Disease images
Number of subjects: 108
Study 30107236 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision aid
Number of subjects: 108
Study 28746180 — intervention group
Group type: EXPERIMENTAL
Intervention: AP-lateral scout view
Number of subjects: 410
Study 28746180 — intervention group
Group type: COMPARATOR
Intervention: AP scout view
Number of subjects: 410
Study 25515174 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-based cognitive training (CBCT) programs
Number of subjects: 18
Study 25515174 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 18
Study 22960477 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive care
Number of subjects: 299
Study 22960477 — intervention group
Group type: COMPARATOR
Intervention: Interdisciplinary care
Number of subjects: 299
Study 22960477 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 299
Study 20421519 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone marrow mononuclear cell therapy
Number of subjects: 0
Study 19175893 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutamine-enriched enteral nutrition during the neonatal period
Number of subjects: 89
Study 19175893 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 89
Study 17001575 — intervention group
Group type: EXPERIMENTAL
Intervention: Simeticone (300 mg) administered 20 min before capsule endoscopy
Number of subjects: 56
Study 17001575 — intervention group
Group type: COMPARATOR
Intervention: No simeticone (control group)
Number of subjects: 56
Study 15155295 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported history of whole-body skin examination
Number of subjects: 2704
Study 15155295 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported history of whole-body skin examination in the past 12 months
Number of subjects: 2704
Study 15155295 — intervention group
Group type: EXPERIMENTAL
Intervention: Demographic factors (women and younger participants)
Number of subjects: 2704
Study 15155295 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants with a history of melanoma
Number of subjects: 2704
Study 11413698 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240
Study 11413698 — intervention group
Group type: COMPARATOR
Intervention: Dimenhydrinate (1 mg x kg‐1)
Number of subjects: 240
Study 11413698 — intervention group
Group type: COMPARATOR
Intervention: Droperidol (15 micrograms x kg‐1)
Number of subjects: 240
Study 11413698 — intervention group
Group type: EXPERIMENTAL
Intervention: Droperidol (15 micrograms x kg‐1) + Dimenhydrinate (1 mg x kg‐1)
Number of subjects: 240
Study 9404370 — intervention group
Group type: EXPERIMENTAL
Intervention: R-salbutamol (200-3200 micrograms)
Number of subjects: 12
Study 9404370 — intervention group
Group type: EXPERIMENTAL
Intervention: RS-salbutamol (400-6400 micrograms)
Number of subjects: 12
Study 9404370 — intervention group
Group type: COMPARATOR
Intervention: S-salbutamol (200-3200 micrograms)
Number of subjects: 12
Study 9404370 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 8215477 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-arterial infusion of mitomycin C combined with PJ-203 (600 +/- 300 mg)
Number of subjects: 60
Study 8215477 — intervention group
Group type: COMPARATOR
Intervention: Intra-arterial infusion of mitomycin C alone (control)
Number of subjects: 60
Study 8215477 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-arterial infusion of mitomycin C combined with PJ-203
Number of subjects: 60
Study 3441275 — intervention group
Group type: EXPERIMENTAL
Intervention: Scopolamine (0.25-0.75 mg i.m.)
Number of subjects: 8
Study 3441275 — intervention group
Group type: EXPERIMENTAL
Intervention: Scopolamine (0.50 and 0.75 mg i.m.)
Number of subjects: 8
Study 3441275 — intervention group
Group type: EXPERIMENTAL
Intervention: Scopolamine (0.75 mg i.m.)
Number of subjects: 8
Study 3441275 — intervention group
Group type: EXPERIMENTAL
Intervention: Scopolamine (0.50 mg i.m.)
Number of subjects: 8
Study 3441275 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 28963591 — intervention group
Group type: EXPERIMENTAL
Intervention: Eight-week supervised exercise program (2×/week for 60 min) including endurance, resistance, and balance training
Number of subjects: 30
Study 28963591 — intervention group
Group type: COMPARATOR
Intervention: Written standard recommendations to obtain physical fitness (Control Group)
Number of subjects: 30
Study 26763774 — intervention group
Group type: EXPERIMENTAL
Intervention: web-based cognitive training (eCogT) with telephone support (n=94)
Number of subjects: 157
Study 26763774 — intervention group
Group type: COMPARATOR
Intervention: waitlist control (WLC) condition (n=63)
Number of subjects: 157
Study 24943741 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention now group
Number of subjects: 0
Study 24943741 — intervention group
Group type: COMPARATOR
Intervention: Intervention later group (waiting list)
Number of subjects: 0
Study 22581039 — intervention group
Group type: EXPERIMENTAL
Intervention: Umesh's intubation detector
Number of subjects: 50
Study 20479485 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose-fructose beverage (GF)
Number of subjects: 9
Study 20479485 — intervention group
Group type: COMPARATOR
Intervention: Glucose-only beverage (G)
Number of subjects: 9
Study 18533979 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediately loaded implants with a coil spring
Number of subjects: 20
Study 18533979 — intervention group
Group type: COMPARATOR
Intervention: Nonloaded implants with an annealed coil spring
Number of subjects: 20
Study 15746784 — intervention group
Group type: EXPERIMENTAL
Intervention: Sharp transection group (n = 41)
Number of subjects: 82